Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-01-22FDA Approved: THIORIDAZINE HYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for thioridazine hydrochloride, with Chartwell RX, LLC as the sponsor.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved a supplemental application for Fluphenazine hydrochloride submitted by Glenmark Pharmaceuticals Inc., USA.
-
FDA approval · 2025-01-22FDA Approved: THIOTHIXENE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for thiothixene from ANI Pharmaceuticals, Inc., updating its labeling under the supplemental review.
-
FDA approval · 2025-01-22FDA Approved: RISPERDAL M-TAB — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for Risperdal M-Tab (risperidone) from Janssen Pharmaceuticals, Inc., updating the product under a s…
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE — Supplemental Application (Wilshire Pharmaceuticals, Inc.)
FDA approved a supplemental application for Perphenazine from Wilshire Pharmaceuticals, indicating an approved modification related to the d…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Fluphenazine hydrochloride from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2025-01-22FDA Approved: PERPHENAZINE AND AMITRIPTYLINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application by Mylan Pharmaceuticals to market a generic fixed-dose combination of perphenazine and amitriptylin…
-
FDA approval · 2025-01-22FDA Approved: ARISTADA — Supplemental Application (Alkermes, Inc.)
The FDA approved a supplemental application for ARISTADA (aripiprazole lauroxil) from Alkermes, Inc.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for fluphenazine hydrochloride from Lannett Company, Inc., under the generic drug approval process.
-
FDA approval · 2025-01-22FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approves a supplemental application for Geodon (ziprasidone) submitted by Viatris Specialty LLC.
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Dr. Reddys Laboratories Inc.)
FDA approved a supplemental application for Fluphenazine hydrochloride from Dr. Reddys Laboratories Inc., indicating a change to the approve…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE DECANOATE — Supplemental Application (Mylan Institutional LLC)
The FDA granted a supplemental approval for fluphenazine decanoate by Mylan Institutional LLC.
-
FDA approval · 2025-01-22FDA Approved: CLOZAPINE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for CLOZAPINE from Mylan Pharmaceuticals Inc. The action relates to a modification of the generi…
-
FDA approval · 2025-01-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., updating the generic product's status as an appr…
-
FDA approval · 2025-01-22FDA Approved: HALOPERIDOL — Supplemental Application (Lannett Company, Inc.)
The FDA approved a supplemental application for HALOPERIDOL submitted by Lannett Company, Inc., authorizing changes to the product's approva…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for fluphenazine hydrochloride from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-01-22FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., confirming regulatory approval of the generic pr…
-
FDA approval · 2025-01-22FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for fluphenazine hydrochloride submitted by PAI Holdings, LLC dba PAI Pharma.
-
FDA approval · 2025-01-16FDA Approved: HALOPERIDOL LACTATE — Supplemental Application (Mylan Institutional LLC)
FDA granted a supplemental approval for HALOPERIDOL LACTATE to Mylan Institutional LLC, issuing a supplemental application for this generic …
-
FDA approval · 2025-01-15FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride from Sandoz Inc., approving a generic product. The action makes th…
-
FDA approval · 2025-01-15FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approves a supplemental application for trifluoperazine hydrochloride (Sandoz Inc.), granting approval of the generic product. Trifluope…
-
FDA approval · 2025-01-15FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc.)
FDA approved a supplemental application for trifluoperazine hydrochloride by Sandoz Inc., enabling its generic product approval.
-
FDA approval · 2025-01-14FDA Approved: TRIFLUOPERAZINE HYDROCHLORIDE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for trifluoperazine hydrochloride from Mylan Pharmaceuticals Inc., enabling a generic version to…
-
FDA approval · 2025-01-13FDA Approved: HALOPERIDOL — Supplemental Application (Fresenius Kabi USA, LLC)
FDA approved a supplemental application for HALOPERIDOL LACTATE, a generic injectable form of haloperidol from Fresenius Kabi USA, LLC.
-
FDA approval · 2025-01-13FDA Approved: ARIPIPRAZOLE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA supplemental approval for ARIPIPRAZOLE by Amneal Pharmaceuticals LLC under an ANDA (ANDA 203906). This document records the supplemental…